Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Accumulated Expenses (2016 - 2025)

INVO Fertility has reported Accumulated Expenses over the past 16 years, most recently at $342957.0 for Q3 2025.

  • Quarterly Accumulated Expenses fell 46.42% to $342957.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $342957.0 through Sep 2025, down 46.42% year-over-year, with the annual reading at $713483.0 for FY2024, 1.21% down from the prior year.
  • Accumulated Expenses was $342957.0 for Q3 2025 at INVO Fertility, down from $365694.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.9 million in Q1 2025 and troughed at $342957.0 in Q3 2025.
  • The 5-year median for Accumulated Expenses is $641823.0 (2022), against an average of $720068.3.
  • Year-over-year, Accumulated Expenses skyrocketed 211.5% in 2023 and then tumbled 46.42% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $581689.0 in 2021, then soared by 62.67% to $946262.0 in 2022, then dropped by 23.67% to $722251.0 in 2023, then decreased by 1.21% to $713483.0 in 2024, then plummeted by 51.93% to $342957.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Accumulated Expenses are $342957.0 (Q3 2025), $365694.0 (Q2 2025), and $1.9 million (Q1 2025).